---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-25-000166"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:15:53.523248+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Salarius Pharmaceuticals corrects false delisting reports; remains listed on Nasdaq

## Summary
- Company statement that stock continues trading on Nasdaq Capital Market under ticker SLRX despite inaccurate Yahoo Finance and CapIQ delisting reports.
- Nasdaq compliance regained: Bid Price Rule (Sep 4, 2025) and Equity Standard (Oct 10, 2025) re-attained.
- Merger with Decoy Therapeutics completed Nov 13, 2025; no delisting notification received from Nasdaq.
- Company contacted financial data platforms to correct erroneous delisting information.

## SEC filing metadata
- accession: 0001615219-25-000166
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000166/0001615219-25-000166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000166/flks-20251117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-25-000166
- JSON: https://secwatch.observer/filing/0001615219-25-000166.json
- Plain text: https://secwatch.observer/filing/0001615219-25-000166.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.